These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 21932407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients.
    Chao YK, Chuang WY, Yeh CJ, Wu YC, Liu YH, Hsieh MJ, Cheng AJ, Hsueh C, Liu HP.
    J Surg Oncol; 2012 Feb; 105(2):183-8. PubMed ID: 22213642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
    Salehi Z, Mashayekhi F.
    Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
    [Abstract] [Full Text] [Related]

  • 6. High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.
    Yeh CJ, Chuang WY, Chao YK, Liu YH, Chang YS, Kuo SY, Tseng CK, Chang HK, Hsueh C.
    Virchows Arch; 2011 Feb; 458(2):171-8. PubMed ID: 21046149
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
    Benavente S, Vergés R, Hermosilla E, Fumanal V, Casanova N, García A, Ramón Y Cajal S, Giralt J.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1316-22. PubMed ID: 19362787
    [Abstract] [Full Text] [Related]

  • 10. COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma.
    Akutsu Y, Hanari N, Yusup G, Komatsu-Akimoto A, Ikeda N, Mori M, Yoneyama Y, Endo S, Miyazawa Y, Matsubara H.
    Ann Surg Oncol; 2011 Oct 01; 18(10):2946-51. PubMed ID: 21437756
    [Abstract] [Full Text] [Related]

  • 11. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.
    Chao YK, Wu YC, Liu YH, Tseng CK, Chang HK, Hsieh MJ, Chu Y, Liu HP.
    J Surg Oncol; 2010 Aug 01; 102(2):158-62. PubMed ID: 20648587
    [Abstract] [Full Text] [Related]

  • 12. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
    Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ, Wu YC, Liu HP.
    Ann Surg Oncol; 2011 Feb 01; 18(2):529-34. PubMed ID: 20697822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic significance of immunohistochemically detected lymph node micrometastases in pT0N0 esophageal squamous cell carcinoma.
    Chao YK, Yeh CJ, Chuang WY, Fan KH, Hsieh MJ, Chu Y, Cheng AJ, Liu HP.
    J Surg Oncol; 2009 Dec 01; 100(7):559-62. PubMed ID: 19653242
    [Abstract] [Full Text] [Related]

  • 15. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT, Wang HW, Chou TY, Hsu WH, Hsu HS, Lin CH, Wang LS.
    Ann Surg Oncol; 2009 Feb 01; 16(2):352-60. PubMed ID: 19050969
    [Abstract] [Full Text] [Related]

  • 16. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
    Fukuchi M, Nakajima M, Miyazaki T, Masuda N, Osawa H, Manda R, Tsukada K, Kato H, Kuwano H.
    J Surg Oncol; 2006 Jul 01; 94(1):51-6. PubMed ID: 16788944
    [Abstract] [Full Text] [Related]

  • 17. Using pretreatment tumor depth and length to select esophageal squamous cell carcinoma patients for nonoperative treatment after neoadjuvant chemoradiotherapy.
    Chao YK, Tseng CK, Wen YW, Liu YH, Wan YL, Chiu CT, Chang WC, Chang HK.
    Ann Surg Oncol; 2013 Sep 01; 20(9):3000-8. PubMed ID: 23584515
    [Abstract] [Full Text] [Related]

  • 18. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
    Wang F, Wang Y, Yu X, Yang D, Wang Z, Lu C, Yuan Z, Xiao M, Shen A.
    J Clin Gastroenterol; 2009 Jul 01; 43(6):520-6. PubMed ID: 19349901
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S.
    Cancer; 2006 Oct 15; 107(8):1801-11. PubMed ID: 16983702
    [Abstract] [Full Text] [Related]

  • 20. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B, Peg V, Vázquez-Sánchez MA, López-Vicente L, Argelaguet E, Coch L, Martínez A, Hernández-Losa J, Armengol G, Ramon Y Cajal S.
    Int J Oncol; 2011 Nov 15; 39(5):1337-45. PubMed ID: 21750861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.